• Mashup Score: 3

    Certain chronic comorbidities, including diabetes, are highly prevalent in people with coronavirus disease 2019 (COVID-19) and are associated with an increased risk of severe COVID-19 and mortality. Mild glucose elevations are also common in COVID-19 patients and associated with worse outcomes even in people without diabetes. Several studies have recently reported new-onset diabetes associated…

    Tweet Tweets with this article
    • RT @Abraham_RMI: @kamleshkhunti et al. COVID-19, Hyperglycemia, and New-Onset Diabetes https://t.co/p7J5yE1cyh CC @fjcarrascos @CarreteroJ…

  • Mashup Score: 5

    The discovery that HbA1c was a valid and reliable measure of average glucose exposure was one of the most important advances in diabetes care. HbA1c was rapidly adopted for monitoring glucose control and is now recommended for the diagnosis of diabetes. HbA1c has several advantages over glucose. Glucose assessment requires fasting, has poor preanalytic stability, and is not standardized;…

    Tweet Tweets with this article
    • ⁦@LizSelvin⁩ ‘s latest outstanding article - ⁦@Hopkins_GIM⁩ Hemoglobin A1c—Using Epidemiology to Guide Medical Practice: Kelly West Award Lecture 2020 | Diabetes Care https://t.co/StIZTMloOZ

  • Mashup Score: 7

    OBJECTIVE To assess whether gestational diabetes mellitus (GDM) is associated with an increased risk of heart failure (HF). RESEARCH DESIGN AND METHODS We conducted a population-based cohort study using information from the Ministry of Health and Long-Term Care of Ontario (Canada) health care administrative databases. We identified all women in Ontario with a GDM diagnosis with a live birth…

    Tweet Tweets with this article
    • RT @kamleshkhunti: Gestational diabetes associated with an 39% ⬆️ risk of heart failure One for you @Elpida_Vnz https://t.co/QmuJ0eIw0v…

  • Mashup Score: 4

    OBJECTIVE Heart failure (HF) is an impactful complication of type 2 diabetes mellitus (T2DM). We aimed to develop and validate a risk score for hospitalization for HF (HHF) incorporating biomarkers and clinical factor(s) in patients with T2DM. RESEARCH DESIGN AND METHODS We derived a risk score for HHF using clinical data, high-sensitivity troponin T (hsTnT), and N-terminal prohormone of B-type…

    Tweet Tweets with this article
    • Among diabetics, a score of hsTn, NT-pro-BNP, and prior HF was associated with HF hospitalization - derived in SAVOR-TIMI 53 & validated in DECLARE-TIMI 58. Thus, greater ARR for dapagliflozin in DECLARE-TIMI 58 with higher scores https://t.co/r2aUklHWoL @ddbergMD @ADA_Journals https://t.co/AWVFr3PLvT

  • Mashup Score: 2

    Improvement of glucose levels into the normal range can occur in some people living with diabetes, either spontaneously or after medical interventions, and in some cases can persist after withdrawal of glucose-lowering pharmacotherapy. Such sustained improvement may now be occurring more often due to newer forms of treatment. However, terminology for describing this process and objective measures…

    Tweet Tweets with this article
    • The original paper in Diabetes Care -> https://t.co/efCilsVXUS